Eculizumab as rescue therapy for severe acute antibody mediated rejection in heart transplant recipients

Authors

Michelle Tomeczkowicz, Advocate Health - MidwestFollow
Tatyana Lawrecki, Advocate Health - MidwestFollow
Nikhil Narang, Advocate Health - MidwestFollow
Mark Joshua Dela Cruz, Advocate Health - MidwestFollow
Ivy Balanlayos, Advocate Health - MidwestFollow
Amanda Jaramillo, Advocate Health - MidwestFollow
Vinh Q. Chau, Advocate Health - MidwestFollow
Anjali Joshi, Advocate Health - MidwestFollow
Mohammad T. Kabbany, Advocate Health - MidwestFollow
Gregory Macaluso, Advocate Health - MidwestFollow
James Monaco, Advocate Health - MidwestFollow
Sunil Pauwaa, Advocate Health - MidwestFollow
Jessica Pillarella, Advocate Health - MidwestFollow
Christopher Sciamanna, Advocate Health - MidwestFollow
William G. Cotts, Advocate Health - MidwestFollow

Recommended Citation

Tomeczkowicz M, Lawrecki T, Narang N, et al. Eculizumab as Rescue Therapy for Severe Acute Antibody Mediated Rejection in Heart Transplant Recipients. The Journal of Heart and Lung Transplantation. 2024;43(4):S640-S641. doi:10.1016/j.healun.2024.02.1014

Affiliations

Advocate Christ Medical Center

Type

Abstract